Navigation Links
Butamax™ and Fagen Announce Collaboration to Retrofit Ethanol Plants for Biobutanol Production
Date:4/19/2012

WILMINGTON, Del., April 19, 2012 /PRNewswire/ -- Butamax™ Advanced Biofuels, LLC, a joint venture between BP and DuPont, announced today that it has entered into collaboration with Fagen, Inc. for the introduction of commercial biobutanol production using Butamax™ technology. Fagen is the world's most experienced biofuels engineering, procurement and construction contractor, having built more ethanol capacity than any other company.  They are the largest, most respected green energy design builder in the U.S. and have constructed over 85 ethanol plants totaling approximately 6 billion gallons of annual production. Fagen's extensive experience with ethanol production facilities and Butamax's pioneering biobutanol technology provides strong synergy for the rapid scale-up of biobutanol production.

(Logo: http://photos.prnewswire.com/prnh/20120419/DE90615LOGO )

(Logo:  http://photos.prnewswire.com/prnh/20120209/MM50763LOGO )

"We are delighted to partner with Fagen on our path to commercialize biobutanol," said Paul Beckwith, Butamax CEO. "Fagen is simply the world leader when it comes to project execution in the biofuels industry, with leading standards for safety and quality. Our shared commitment to renewable energy makes Fagen a natural partner for Butamax and our shareholders."

"Butamax offers an exciting opportunity for ethanol facilities to leverage their existing assets to produce the next generation biofuel," said Aaron Fagen, CEO Fagen, Inc., "We look forward to working with Butamax in the deployment of their commercial strategy and their first retrofit project starting in 2013." 

Butamax was the first company to identify the opportunities and technology for cost-effective production of isobutanol through advanced biotechnology.  The company announced last December the formation of the Early Adopters Group (EAG), a consortium of world-class biofuel production companies interested in becoming early adopters of Butamax™ biobutanol technology. In addition, piloting work continues at the Butamax Technology Demonstration facility as the company prepares for market entry with commercial production in 2014.

About Butamax

Butamax™ Advanced Biofuels, LLC was formed to develop and commercialize biobutanol as a next generation renewable biofuel for the transport market. The company benefits from the synergy of DuPont's proven industrial biotechnology experience and BP's global fuels market knowledge. Butamax's proprietary technology offers a cost-advantaged manufacturing process for isobutanol with value from field to pump. For more information about Butamax, visit www.butamax.com.

About Fagen

Fagen, Inc. is a full service industrial contractor and the largest green energy design-builder in the U.S. Utilizing a database of over 25,000 highly skilled craftworkers, Fagen, Inc. has constructed 60% of the ethanol production capacity in the United States, as well as multiple wind, solar, and power projects. The unmatched standard for safety, quality, and service has led Fagen, Inc. to be consistently listed in the Top 400 Contractors by Engineering News Record. For more information about Fagen, visit www.fageninc.com.

Butamax™ is a trademark of Butamax™ Advanced Biofuels, LLC.

Butamax Contact: Pam Schools

910-777-7119

pamela.schools@butamax.com


Fagen, Inc. Contact: Becky Dahl

320-564-5263

bdahl@fageninc.com


'/>"/>
SOURCE Butamax Advanced Biofuels, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Butamax™ Responds to Gevo Patent Infringement Lawsuit
2. Goodwin Biotechnology and RAFAGEN Announce a Collaboration
3. Medivir Announces TMC435 in an Expanded Clinical Collaboration
4. Inspiration Biopharmaceuticals Announces Filing of Biologics License Application (BLA) for IB1001, a Recombinant Factor IX Product for People with Hemophilia B
5. CardioInsight Announces Appointment of Jim Bullock as Chairman of the Board of Directors
6. WaferGen Bio-systems Announces Open Format qPCR Platform and Strategic Realignment
7. Custom Spine Announces 510K Clearance for Securis Cannulated Screw System
8. UBM Canon, the Global MedTech Authority, and the Medical Design Excellence Awards Announce Dean Kamen as the Presenter of the 2012 Lifetime Achievement Award
9. BioRestorative Therapies Announces Closing of License Agreement for Adult Stem Cell Disc/Spine Procedure
10. Islet Sciences Announces Receipt of $2.1 Million in Grant Support of Technology
11. ADVENTRX Announces Establishment of Regulatory Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... and GREENWICH, Conn. , ... investment firm focused on venture growth investments in ... of Josh Richardson , M.D. to Managing ... in biotechnology companies.  He is a board observer ... roles in Longitude,s investments in Aimmune Therapeutics, Akebia ...
(Date:2/16/2017)... 16, 2017  ArmaGen, Inc., a privately held ... treat severe neurological disorders, today reported preliminary evidence ... the company,s investigational therapy for the treatment of ... type I, or MPS I). The initial results ... presented today at the 13 th annual ...
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... , February 16, 2017 ... the infusion of innovative telemedicine application, new and ... that are experiencing a boom worldwide. The healthcare ... advancement of technologies, services and new therapies for ... RQHTF) (TSX-V: RHT), Cellectar Biosciences, Inc. (NASDAQ: ...
Breaking Biology Technology:
(Date:2/8/2017)... YORK , Feb. 7, 2017 Report Highlights ... The ... should reach $11.4 billion by 2021, growing at a compound ... Includes - An overview of the global markets for synthetic ... 2015, estimates for 2016, and projections of compound annual growth ...
(Date:2/7/2017)... 2017 Ipsidy Inc. ( www.ipsidy.com ... IDGS], ("Ipsidy" or the "Company") a provider of secure, ... is pleased to announce the following changes as part ... January 31, 2017, Philip D. Beck was ... President.  An experienced payment industry professional and public company ...
(Date:2/2/2017)... -- EyeLock LLC, a market leader of iris-based identity authentication ... You Should Know About Biometrics in the Cloud ."  ... a growing concern. In traditional schemes, cryptography is used ... schemes such as username/password suffer from inherent weaknesses. ... elegant solution to the problem of high-security user authentication. ...
Breaking Biology News(10 mins):